Macau Revenue Down 21.2% In December
According to data released by the Macao Gaming Inspection and Coordination Bureau, gaming revenue in the month of December came in at 18.3 billion patacas, about 21 percent lower than December 2014’s number.
The Best Stock Ideas Of December
The S&P 500 declined by a modest 1.2 percent in December, finishing off a 2015 that saw very little change from start to finish. The index finished 2015 down 0.73 percent.
Every Biotech Catalyst Wedbush Is Watching In 2016
In a new report, Wedbush analyst Liana Moussatos breaks down potential 2016 catalysts for every emerging pharmaceuticals stock under the firm’s coverage. Overall, Wedbush is very bullish about these 11 Outperform-rated stocks headed into 2016. Carbylan Therapeutics Inc CBYL 5.21% Wedbush expects approval of Hydros-TA by early 2018 and a launch by mid-2018. The firm…
This Hedge Fund Manager’s Worst Ideas For 2016 May Surprise You
Note: do yourself a favor and click on the link to Mr. DeMuth’s full article. It is very well-written and informative. If you do not understand why the ideas he is describing are terrible ideas, you will have a hard time trading stocks successfully. Reasons number six and seven are particularly important and remind me of…
4,214% Interest Rate Payday Loans? Yes, They’re Real
All over the country, payday loan businesses seem to be popping up promoting “fast cash now.” While technically legal in most U.S. states, these payday lenders have quickly gained a bad reputation for predatory behavior. Unfortunately, many payday loan customers have no idea how badly they are being taken advantage of, or that there’s now…
Don’t Wait Until You’re 30 To Start Investing
When you’re young, retirement seems like a lifetime away. However, in reality, the financial decisions you make in your 20s have a much larger impact on your financial security laterIin life than you may think.
The Software Stocks That Worked (And Didn’t) In 2015
In a new report, MKM Partners analyst Kevin Buttigieg took a look back at the enterprise software industry and discussed investing themes that have worked and those that haven’t over the past two years.
Here’s What Wall Street Thinks Of Chimerix After The Crash
Chimerix Inc CMRX 3.58% shares were crushed on Monday, as the stock fell more than 80 percent following news that its brincidofovir SUPPRESS study fell short of endpoint expectations in the prevention of cytomegalovirus (CMV) infection.